Two Types of Single-use Flexible Ureteroscopies for the Treatment of Upper Urinary Tract Stones in Children

ConditionUrinary Stone
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-14
SponsorThe Children's Hospital of Zhejiang University School of Medicine

About this trial

The single-use digital flexible Ureteroscopy (fURS) is commonly used for the treatment of upper urinary tract stones. The size of the outer diameter of the fURS can affect the safety, efficacy, and medical costs of the treatment. Particularly for children, their ureters are thinner and more tortuous compared to adults, which places higher demands on medical devices. The investigators are interested in determining if the performance of the two different sizes of fURS (6.3 Fr vs. 8.6 Fr) are equivalent. This study will have guiding significance for the selection of upper urinary tract stones surgery in children in the future.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients scheduled for ureteroscopy and laser lithotripsy for individual renal stones ranging in size from 5 mm to 20 mm in all intrarenal locations (If there are multiple stones present, the total stone burden in cross section should not exceed 20 mm)

Patients < 14 years

For children younger than 8 years old, the informed consent form is signed by the parents; for children older than 8 years old, the informed consent form is signed by both the parents and the child themselves.

Disqualifiers

Children with uncontrolled urinary tract infections or coagulation disorders and other contraindications for surgery before the operation.

Children with severe renal insufficiency, anatomical or functional solitary kidney, known nephrocalcinosis, and other significant comorbidities that are not suitable for participating in the study.

Children who refuse to participate in this study.

Any other reason that in the opinion of the investigator would make the participant unsuitable for enrollment in the study.

Trial design

Design model

Parallel

Treatments tested in this trial

  • 8.6 Fr single-use fURS (XFGC-FU-660RC)

    Device

    Comparative device

  • 6.3 Fr single-use fURS (Hugemed, HU30S)

    Device

    Device being tested

Treatment groups

52 Participants
are divided into 2 treatment groups
Group A: 8.6 Fr single-use fURS (XFGC-FU-660RC)Active comparator 1 intervention
Group B: 6.3 Fr single-use fURS (HugeMed, HU30S)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

The success rate of the first fURS insertion

The first insertion of fURS is successful without the need for balloon dilation or passive dilation with a stent.

Time frame
During the procedure

Secondary outcomes

1

Ureteral access sheath placement (Yes/No)

Whether a ureteral access sheath is placed during the procedure

Time frame
During the procedure
2

Balloon dilation rate

Due to difficulty in passing the fURS through the ureter, balloon dilation of the ureter is performed during the procedure

Time frame
During the procedure
3

Pre-placement rate of double-J stents

Due to difficulty in passing the fURS through the ureter, the double-J stent is placed during the surgery to passively dilate the ureter, facilitating a second-stage fURS procedure

Time frame
During the procedure
4

Surgical duration

From the initiation of fURS insertion to the completion of lithotripsy, the fURS is withdrawn from the body

Time frame
During the procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.